baber/WOPTO huggingface dataset:
Patent AU-568506-B2 (AU)
Title: A universal section for a demountable partitioning system
Inventor: THOBURN JOHN GRAHAM
IPC: E04B2/82
Filed: 1983-09-05
Granted: 1988-01-07
Abstract: A demountable partitioning system comprises multipurpose aluminium extrusions adapted to be snap-fitted together in a number of different configurations to suit different constructional and system design requirements. The system centres around two universal sections (FW1.FW11) each in the form of a rectangular channel open at one side and provided with formations (3,4,5) enabling other extrusions selected from a glazing infill section (FW3), a blank end section (FW4), and a door infill section (FW5) each provided with complementary formations (8,10) to be snap-fitted onto one or more sides of the universal section (FW1,FW11). Extruded aluminium or plastics glazing channels (FW6,FW7,FW8) capable of engaging with a number of different glazing beads (FG) can be snap-fitted with the universal sections (FW1,FW11) and with the glazing infill (FW3) for assembling single or double glazing as desired to the universal sections (FW1, FW11). The universal sections (FW1,FW11) also can engage with wall panels of a partitioning installation. Fixing clips (FS1,FS2,FS3 and FS4) are disclosed which enable gapless panel joints to be made, and the system further includes corner and reducing sections (FW9,FW10) and wiring ducting sections (FW13, FW14,FW15). The system is cost advantageous, can be installed quickly and is readily demountable and reusable, and requires a minimum of secondary fixings (screws, bolts, etc.).
Patent AU-617959-B2 (AU)
Title: Method to achieve a linear standard curve in a sandwich immunoassay
Inventor: TUNG KER-KONG
IPC: G01N33/543
Filed: 1988-04-13
Granted: 1991-12-05
Abstract: A method for obtaining an actual linear standard curve in a sandwich type of immunoassay where a first antibody bound to an insoluble support and a second unbound labelled antibody complex with the antigen contained in a test sample to form an insoluble antibody:antigen:labelled antibody complex which is then detected. Unbound unlabelled first antibody and/or unbound unlabelled second antibody are added to the reaction mixture to divert excess antigen away from the desired end-product complex, thus rendering the antigen of interest the rate-limiting factor in the overall immunoreaction. This results in a pseudo first-order reaction which produces an actual linear standard curve.
Patent AU-600634-B2 (AU)
Title: Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
Inventor: CAMPBELL PATRICIA S
IPC: A61K9/70
Filed: 1988-08-09
Granted: 1990-08-16
Abstract: A method for preventing the formation of crystalline hydrates in a dispersion of a hydratable liquid in a nonaqueous matrix is disclosed. The method is particularly useful in the manufacture of laminated items formed from such dispersions and comprises forming individual subunits from such dispersions, heating the subunits, preferably after they have been packed in sealed containers, to a temperature high enough to melt the crystalline hydrate, maintaining said subunits at such temperature for a time sufficient to melt all the crystalline hydrate present and to prevent the occurrence of crystals for an extended period of time after cooling and cooling subunits to ambient conditions. The use of the method in the manufacture of transdermal delivery devices for the delivery of scopolamine base is described.
Patent AU-779565-B2 (AU)
Title: Methods and means for modification of plant characteristics using the vernalization gene VRN2
Inventor: DEAN CAROLINE
IPC: C07K14/415
Filed: 2000-01-28
Granted: 2005-01-27
Abstract: An isolated nucleic acid obtainable from the VRN2 locus of a plant, which nucleic acid encodes a polypeptide which is capable of affecting one or more physical characteristics of a plant into which the nucleic acid is introduced, the physical characteristics being selected from vernalization response, flowering time, leaf size, and/or shape or shade avoidance response; alleles, fragment and derivatives thereof; polypeptides encoded by such nucleic acids; antibodies to such peptides.
Patent AU-613083-B2 (AU)
Title: A method for the determination of soluble fibrin
Inventor: BECKER UDO
IPC: G01N33/86
Filed: 1988-09-07
Granted: 1991-07-25
Abstract: The method entails use of a labelled bioaffinity binding partner, which is bound to a solid phase, for fibrin in a body fluid.
Patent AU-603927-B2 (AU)
Title: A lubricant comprising an oil-in water emulsion, a process for the preparation thereof and the use of the lubricant
Inventor: GARVEY MICHAEL JOSEPH
IPC: C10M173/00
Filed: 1988-09-19
Granted: 1990-11-29
Abstract: A lubricant comprising an oil-in-water emulsion and solid particles, in which the oil is a lubricating material and the oil droplets are stabilized by a surface coating of partially hydrophobic silica particles of a size less than 1 micrometer. This lubricant is to be used as a hydraulic fluid and as a metal-working or metal-rolling fluid.
Patent AU-686384-B2 (AU)
Title: Duloxetine enteric pellets
Inventor: ANDERSON NEIL ROBERT
IPC: A61K31/381
Filed: 1995-07-17
Granted: 1998-02-05
Abstract: A superior enteric formulation of the antidepressant drug, duloxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
Patent AU-760921-B2 (AU)
Title: Insecticidal seed coating
Inventor: CHEN YUGUANG
IPC: A01N51/00
Filed: 1998-12-14
Granted: 2003-05-22
Abstract: The pesticide to be used without causing phytotoxicity to the seed. Insecticidal coating for a corn seed comprises: (1) one or more binders comprising polymers or copolymers of polyvinylacetate, methyl cellulose, polyvinyl alcohol, vinylidene chloride, acrylic, cellulose, polyvinylpyrrolidone or polysaccharide; (2) an insecticidal heterocycle of formula (I) or its tautomer or salt, optionally in combination with imidacloprid or its analogues, organophosphate, phenyl pyrazole and/or a pyrethroid: and (3) one or more fillers, where the binder forms a matrix for the insecticide and filler on the corn seed and the filler is present in an amount to prevent or reduce the phytotoxic effect on the corn seed caused by the insecticide. The coated seed is claimed per se. [Image] A : optionally mono- to tetrasubstituted, optionally aromatic, mono- or bicyclic heterocycle, where 1-2 of the substituents are Q aand 1-4 of the substituents are Q b; Q a1-3C haloalkyl, cyclopropyl, halocyclopropyl, 2-3C alkenyl, 2-3C alkynyl, 2-3C haloalkenyl, 2-3C haloalkynyl, 1-3C haloalkoxy, 1-3C alkylthio, 1-3C haloalkylthio, allyloxy, propargyloxy, allylthio, propargylthio, haloallyloxy, haloallylthio, CN or NO 2; Q b1-3C alkyl, 1-3C alkoxy or halogen; R = H, 1-6C alkyl, phenyl-1-4C alkyl, 3-6C cycloalkyl, 2-6C alkenyl or 2-6C alkynyl; and X : N-NO 2or N-CN. Independent claims are included for the following: (1) control of insect pests from damaging a corn plant comprising applying the above coating to a corn seed; (2) preparation of coated corn seeds; and (iii) a method of protecting emerging seedlings of a crop plant form one or more insect organisms in the seed growing soil environment comprising applying the above coating to he seeds. ACTIVITY : Insecticide;.
Patent AU-615705-B2 (AU)
Title: Adenosine deaminase-stable anti-retroviral nucleosides
Inventor: HAERTLE THOMASZ
IPC: C07H19/00
Filed: 1988-11-17
Granted: 1991-10-10
Abstract: Adenine deaminase-stable adenine derivatives bonded 9,1' to a furanosidyl ring containing a 5'-hydroxyl group are described. These compounds are useful in a method of inhibiting replication of reverse transcriptase-dependent viruses.
Patent AU-776851-B2 (AU)
Title: Stable emulsion compositions
Inventor: SATO JUN
IPC: A61K47/44
Filed: 2001-02-01
Granted: 2004-09-23
Abstract: An emulsion composition containing a compound represented by the formula: <CHEM> wherein R is an aliphatic hydrocarbon group optionally having substituents, an aromatic hydrocarbon group optionally having substituents, a heterocyclic group optionally having substituents, a group represented by the formula: -OR<1> (wherein R<1> is a hydrogen atom or an aliphatic hydrocarbon group optionally having substituents) or a group represented by the formula: <CHEM> wherein R<1b> is a hydrogen atom or an aliphatic hydrocarbon group optionally having substituents, R<1c> is the same as or different from R<1b> and is a hydrogen atom or an aliphatic hydrocarbon group optionally having substituents, R<0> is a hydrogen atom or an aliphatic hydrocarbon group, or R and R<0> in combination represent a bond, Ar is an aromatic hydrocarbon group optionally having substituents <CHEM>  or <CHEM> and the like, and n is an integer of 1 to 4, a salt thereof or a prodrug thereof, wherein the composition is adjusted to have a pH of not more than about 6, shows improved stability of the compound, a salt thereof or a prodrug thereof, and realizes expression of superior efficacy.
Patent AU-701342-B2 (AU)
Title: Reconstituted human antibody against human interleukin-8
Inventor: MATSUSHIMA KOUJI
IPC: C12P21/08
Filed: 1995-07-12
Granted: 1999-01-28
Abstract: A reconstituted human antibody against human interleukin-8 (IL-8), comprising (A) L chains comprising: (1) the human L-chain C region, and (2) the L-chain V region containing the human L-chain FR and the L-chain CDR of a mouse monoclonal antibody against IL-8; and (B) H chains comprising: (1) the human H-chain C region, and (2) the H-chain V region containing the human H-chain FR and and the H-chain CDR of a mouse monoclonal antibody against IL-8. As the major part of the reconstituted antibody derives from a human antibody and antigenicity of the CDR is low, this antibody has a low antigenicity against the human body, thus being expected to be applicable for medical therapy.
Patent AU-689437-B2 (AU)
Title: Roll formed metal member with reinforcement indentations
Inventor: BODNAR ERNEST ROBERT
IPC: E04C3/09
Filed: 1992-11-25
Granted: 1998-04-02
Abstract: PCT No. PCT/CA92/00514 Sec. 371 Date Mar. 1, 1995 Sec. 102(e) Date Mar. 1, 1995 PCT Filed Nov. 25, 1992 PCT Pub. No. WO94/05872 PCT Pub. Date Mar. 17, 1994.A metal member having at least one edge formation, and a web extending from the edge formation, a plurality of generally triangular openings formed in the web at spaced intervals, the triangular formations being alternately reversed relative to one another, a plurality of generally diagonal struts extending between adjacent triangular openings, edge portions along either edge of the web portion, with the struts extending from one said edge portion to the other and merging integrally therewith, flange formations formed from the web around the generally triangular openings, and lying at an angle thereto, whereby to form the diagonal struts with a generally channel shaped cross section, and forming intermittent flanges along the web edges at the base of each triangular opening, the triangular openings defining generally curved corners, and, generally three-sided indentations formed in the web edge at the roots of each of the diagonal struts.
Patent AU-615554-B2 (AU)
Title: Thiophenol derivatives as collagenese inhibitors
Inventor: HUGHES IAN
IPC: A61K31/16
Filed: 1989-06-20
Granted: 1991-10-03
Abstract: Novel compounds of formula (I), salts, solvates and hydrates thereof:   <CHEM>  in which: R1 and R2 are independently hydrogen; alkyl; alkoxy; halogen; or CF3;  R3 is hydrogen; acyl, such as   - @-alkyl or - @ - Z, where Z is optionally substituted aryl; or a group R-S- where R is an organic residue such that the group R-S- provides an in vivo-cleavable disulphide bond;  R4 is C3-6 alkyl; R5 is hydrogen; alkyl; -CH2-R10 where R10 is optionally substituted phenyl or heteroaryl;  or a group <CHEM> where R11 is hydrogen; alkyl; or -CH2-Ph where Ph is optionally substituted phenyl; and R12 is hydrogen or alkyl; and  R6 is hydrogen; alkyl; or a group <CHEM> where R13 is hydrogen; or alkyl; and R14 is hydroxy; alkoxy; or -NR7R8 where each of R7 and R8 is hydrogen or alkyl, or R7 and R8 together with the nitrogen atom to which they are bonded form a 5-, 6- or 7- membered ring with an optional oxygen, sulphur or optionally substituted nitrogen atom in the ring; or R5 and R6 are joined together as -(CH2)m- where m is an integer from 4 to 12; X is (CH2)n where n is 0, 1, or 2; and Y is CH2, processes for their preparation and their use as collagenase inhibitors.
Patent AU-559267-B2 (AU)
Title: Container with spout and dispensing closure
Inventor: CONTI RINO
IPC: A47G19/32
Filed: 1984-12-21
Granted: 1987-03-05
Abstract: A dispenser comprising: a storage container having a peripheral wall terminating in a top rim which circumscribes a wide container mouth, and having a container spout formed to project outwardly of said wall and to bound a substantially U-shaped spout opening formed in the upper extent of said wall, and a cover having a circumferential skirt portion, a cover spout being formed to project outwardly of said skirt portion to bound an inverted U-shaped spout opening formed in the lower extent of said skirt portion; the cover spout being complementary in shape to said container spout; and the cover being adapted to be received over the mouth of said container with said cover spout covering said container spout opening.
Patent AU-571931-B2 (AU)
Title: Moulded fixing device
Inventor: HEPWORTH PAUL STEABBEN
IPC: F16B13/04
Filed: 1985-01-09
Granted: 1988-04-28
Abstract: The invention concerns a fixing device for securing fasteners such as bolts into concrete or other similar material. The device comprises a sleeve member (2, 4) having a block portion (6) in which a nut (14) is set. The block portion (6) has a frusto-conical extension portion (16) joined by shearable links (18) to an intermediate portion (20) of the member which has an internal frusto-conical surface (22) complementing the extrusion portion (16) of the block portion. 
<??>Tightening the bolt shears the links in the usual way. According to the present invention the device is moulded in two longitudinally divided portions (2) and (4), hinged together by a plastics hinge (10) adjacent the block portion (6). In the as-moulded conditions the portions (2, 4) are arranged end-to-end, but are hinged together to form the device ready for use.
Patent AU-750623-B2 (AU)
Title: Methods and substances for preventing and treating autoimmune disease
Inventor: LANGRIDGE WILLIAM H R
IPC: A61K48/00
Filed: 1999-04-21
Granted: 2002-07-25
Abstract: A plant-based edible vaccine against autoimmune disease prepared by expressing a CTB-autoantigen chimeric gene construct in plant cells and transgenic plants is disclosed. DNA constructs, expression vectors comprising a nucleotide sequence that encodes a CTB-autoantigen chimeric gene, which are optimized for expression in plants, are described.
Patent AU-669700-B2 (AU)
Title: Safety device for a box
Inventor: HOLMGREN BERTIL
IPC: A47F7/024
Filed: 1993-03-23
Granted: 1996-06-20
Abstract: PCT No. PCT/SE93/00241 Sec. 371 Date Sep. 22, 1994 Sec. 102(e) Date Sep. 22, 1994 PCT Filed Mar. 23, 1993 PCT Pub. No. WO93/19268 PCT Pub. Date Sep. 30, 1993Safety device to be mounted on a parallelepipedic box comprises a frame (10) constructed to encircle the box and having an insert opening (11) for the box and a blocking element (13) displaceably and pivotably mounted to the frame, the blocking element being adjustable between a blocking position and an off position to prevent in the blocking position the box inserted into the frame from being withdrawn from the frame. A spring blade (22) clamped at one end thereof in the blocking element extends in the displacement path of the blocking element to engage at the other, free end thereof behind a shoulder (25) on the frame and thus to prevent displacement of the blocking element in the blocking position, wherein positive engagement is established between the blocking element and the frame in order to prevent the blocking element from pivoting. The spring blade can be actuated by external assembly in order to release the blocking element for adjustment to the off position by displacement or pivotal movement and thus allowing the box to be withdrawn from the frame through the insert opening.
Patent AU-662420-B2 (AU)
Title: 5-O-desosaminylerythronolide A derivative
Inventor: ASAKA TOSHIFUMI
IPC: C07D491/00
Filed: 1993-04-21
Granted: 1995-08-31
Abstract: Object: to provide a novel macrolide antibiotic having a potent antibacterial activity. Constitution: a tricyclic carbamate derivative of a 3-oxo-6-methoxy-substituted 5-O-desosaminylerythronolide A derivative represented by general fomula (I), and a pharmaceutically acceptable acid addition salt thereof. In formula (I), -A-- represents -N(R<3>)- (wherein R<3> represents hydrogen or C1-C3 alkyl) or -N=; and R<1> and R<2> represent each C1-C3 alkyl. An intermediate, represented by general formula (II), useful for producing the 3-oxo-substituted 5-O-desosaminylerythronolide A derivative, wherein R<4> represents acetyl or propionyl. <CHEM>
Patent AU-729471-B2 (AU)
Title: Machine for transport of passengers and cargo
Inventor: HENDERSON J KIRSTON
IPC: B61F13/00
Filed: 1997-09-04
Granted: 2001-02-01
Abstract: An electrically powered vehicle transportation system utilizes a guideway with parallel enclosed rails. Each enclosed rail has an electrical bus bar for supplying power to vehicles on the guideway. The guideway will accommodate dual-mode vehicles that are capable of usage on conventional streets as well as on the guideway. The guideway also accommodates conventional vehicles and ferries that operate only on the guideway. The enclosed rails have a downward facing slot on an inner wall. The vehicle axles are offset, with a portion extending through each slot. The dual-mode vehicle has a body with axles that are extensible. The axles move from a retracted position, with the wheels recessed within the wheel wells, to an extended position. In the extended position, the wheels locate within the enclosed rails. Conventional vehicles and freight are carried on ferries that move along the guideways.
Patent AU-612284-B2 (AU)
Title: A dispenser-container for wet tissues, and a process for manufacturing the same and an apparatus therefor
Inventor: NAKAMURA KENJI
IPC: A47K10/36
Filed: 1989-10-13
Granted: 1991-07-04
Abstract: A dispenser-container for wet tissues comprises wet tissues (3) impregnated with liquid and a container (1), which is a cylinder, a box or a bag made of a flexible and impervious sheet, having the wet tissues (3) contained therein. The tissues (3) are made of a continuous sheet-like material which has weakened lines for separating therealong at a predetermined distance or are made of a plurality of short tissues (3), adjacent edges of which short tissues are partially overlapped with each other. The wet tissues (3) contained in the container (1) are formed in a rope-like or tape-like shape. Processes for manufacturing the dispenser-container for wet tissues, and apparatuses for manufacturing the dispenser-container for wet tissues.
Patent AU-698221-B2 (AU)
Title: TCF mutant
Inventor: KINOSAKI MASAHIKO
IPC: C07K14/475
Filed: 1995-12-27
Granted: 1998-10-29
Abstract: The present invention relates to TCF mutant having a novel amino acid sequence which is obtained by mutagenesis of one or more amino acid between N-terminus and the first kringle of the amino acid sequence of native TCF and has lowered affinity to heparin and/or elevated biological activity. The present TCF mutant is prepared by gene manipulation of TCF. The TCF mutants of the present invention have proliferative activity and/or growth stimulative activity in hepatocyte and beneficial as a therapeutic agent for various hepatic diseases and an antitumor agent.
Patent AU-715555-B2 (AU)
Title: Method of producing active immunity with vaccine conjugate
Inventor: THOMA JOHN A
IPC: A61P31/04
Filed: 1997-09-26
Granted: 2000-02-03
Abstract: A method of producing active immunity against a bacterial or protozoal disease in a subject comprises administering to the subject a vaccine conjugate comprising a live bacteria or protozoa and a neutralizing factor bound to the live bacteria or protozoa. The neutralizing factor is selected from the group consisting of antibodies and antibody fragments. The live bacteria or protozoa is one capable of producing disease in the subject, and the antibody or antibody fragment is one capable of neutralizing the live bacteria or protozoa.
Patent AU-616116-B2 (AU)
Title: Sonet receive signalling translator
Inventor: BAYDAR ERTUGRUL
IPC: H04J3/00
Filed: 1990-05-04
Granted: 1991-10-17
Abstract: The four signaling bits contained in the eight-bit SONET signaling bytes are read from the SONET signaling row and are converted to four parallel signaling bits for storage in a RAM (10) in quasi-SONET format with sets of four A, four B, four C and four D bits for four consecutive channels being stored for an even and an odd tributary in one RAM memory row. Storing sets of four of the same bit for four consecutive channels simplifies the RAM write operation. A read-modify-write system (16) is used for updating the RAM storage, wherein a row of the RAM (10) is read, modified by eight new signaling bits from two consecutive SONET signaling bytes and is rewritten into the RAM (10). New signaling bits are stored to accumulate eight new signaling bits for two tributaries prior to updating the RAM (10) with the new bits for both tributaries. The 32 signaling bits output during a RAM (10) read operation are selectively multiplexed to output only for bits associated with a particular channel. <IMAGE>
Patent AU-698946-B2 (AU)
Title: A multi-user communication system architecture with distributed receivers
Inventor: MILLER DAVID S
IPC: H04J13/00
Filed: 1996-03-29
Granted: 1998-11-12
Abstract: Method and apparatus for receiving signals in gateways for satellite repeater type spread spectrum communication systems making more efficient use of data transfer capacity and diversity processing. Several communication signals are received by multiple analog receivers and converted into digital format. The digital communication signals are transferred from each analog receiver into a series of demodulation or FHT modules in which they are first despread into encoded data symbols using predetermined PN coding sequences, and then mapped into symbol energy metrics using orthogonal transformers, such as fast Hadamard transformers. The transformation output for each communication channel from each analog receiver is input to a single metric receiver for a data channel or subscriber, where it is subjected to conventional metric signal processing to reconstruct the data. A set of dedicated modules is coupled to each analog receiver for handling each diversity path or subscriber active communication system channel being transferred through that receiver or analog path. Each demodulation or FHT module comprises despreading elements and FHT components that are easily distributed in processing arrays within the gateway.
Patent AU-774189-B2 (AU)
Title: Cargo vehicle wall
Inventor: CLIFFORD D ARCY DAVID
IPC: B62D29/00
Filed: 2000-06-29
Granted: 2004-06-17
Abstract: A cargo vehicle has lightweight rigid panels formed of metal skins and intervening paper layer. Laminate panels are formed using a heated press.
Patent AU-564688-B2 (AU)
Title: Phenoxazine derivatives (resorufin)
Inventor: NEUMANN ULRICH
IPC: C07D209/34
Filed: 1986-05-01
Granted: 1987-08-20
Abstract: The present invention provides a lipase substrate of the general formula:   <IMAGE>   wherein A is an alkylene or alkenylene radical containing up to 16 carbon atoms, R and R1, which can be the same or different, each signify an alkyl, alkenyl or acyl radical containing up to 20 carbon atoms or an optionally alkyl-substituted aryl or aralkyl radical containing up to 8 carbon atoms in the alkyl moiety and wherein one of R and R1 can also be a hydrogen atom, X is the residue of an aromatic hydroxy or thiol compound, and each Y and Z, independently from each other, is -S- or -O-, Z also -CH2-. The present invention also provides a process and a reagent for the optical determination of lipase.